Seagen Inc (SGEN) News Headlines

▮ More

Date

Headline

5/23/2022 8:19:26 AM Seagen Announces Positive Topline Results Of Phase 2 MOUNTAINEER Trial Of TUKYSA With Trastuzumab

5/23/2022 8:05:09 AM Seagen Announces Positive Topline Results Of Phase 2 Trial Of TUKYSA With Trastuzumab In HER2-Positive MCRC

5/16/2022 6:17:05 AM Seagen Board Accepts Resignation Of Clay Siegall - Quick Facts

5/16/2022 6:03:26 AM Seagen Reveals Resignation Of CEO Clay Siegall; Says Roger Dansey To Continue As Interim CEO

5/9/2022 7:03:36 AM Seagen CEO Clay Siegall Takes Leave Of Absence; Roger Dansey Named Interim Chief

5/9/2022 6:03:12 AM Seagen President, CEO And Chairman Clay Siegall Takes Leave Of Absence

4/28/2022 4:43:34 PM Seagen Inc Q1 Loss increases, but beats estimates

4/28/2022 4:20:01 PM Seagen Q1 Loss/share $0.74 Vs. Loss $0.67 Year Ago

4/28/2022 3:00:39 PM Seagen Q1 22 Earnings Conference Call At 4:30 PM ET

4/20/2022 9:03:56 AM Seagen Plans To Build New Facility In Everett, Washington

3/16/2022 7:08:14 AM Seagen, Sanofi In Deal To Develop And Commercialize Multiple Novel Antibody-Drug Conjugates

3/16/2022 6:36:51 AM Seagen And Sanofi Collaborate To Commercialize Multiple Novel Antibody-Drug Conjugates For Up To Three Cancer Targets

2/28/2022 8:54:02 AM Seagen : CHMP Confirms Positive Opinion For PADCEV In Metastatic Urothelial Cancer

2/28/2022 8:08:56 AM Astellas Announces CHMP Confirms Positive Opinion For PADCEV In Locally Advanced Or Metastatic Urothelial Cancer

2/10/2022 5:14:10 PM William Blair Reiterates Seagen Inc (SGEN) At Outperform

2/10/2022 9:58:26 AM Seagen Slides 14% As Loss Widens, Misses Consensus; Outlook Below View

2/9/2022 4:26:44 PM Seagen Announces FY22 Revenue Outlook

2/9/2022 4:08:29 PM Seagen Q4 Loss/share $0.95 Vs. Profit $0.90 Year Ago

2/9/2022 4:07:56 PM Seagen Inc Q4 Earnings Summary

2/9/2022 6:00:21 AM Seagen Q4 21 Earnings Conference Call At 4:30 PM ET